Characteristics of diffuse large B cell lymphoma (DLBCL) diagnosed after systemic lupus erythematosus (SLE)
| At diagnosis | ||
|---|---|---|
| Stage IV disease | 10/13 | (77%) |
| Extranodal disease | 11/13 | (85%) |
| IPI score 3 or 4 | 7/11 | (63%) |
| History of SOT | 2/11 | (18%) |
IPI, International Prognostic Index; SOT, solid organ transplant.